塔利莫基因拉赫帕雷普维克 (T-VEC):在跨越多种癌症类型的瘤病毒疗法中扩大视野
Run-Bin Tan1, Yeannie Hui-Yeng Yap1
1Division of Applied Biomedical Sciences and Biotechnology, School of Health Sciences, IMU University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia.
Anti-cancer agents in medicinal chemistry
|May 7, 2025
概括
塔利摩根拉赫帕雷普韦克 (T-VEC) 是一种瘤性病毒疗法,在黑色素瘤之外显示出有前途,包括乳腺癌和头癌. 研究正在探索其与化疗和放射治疗的结合潜力,以增强抗瘤免疫力.
科学领域:
- 瘤治疗性病毒疗法
- 癌症免疫疗法癌症免疫疗法
- 疹简单病毒1型 (HSV-1) 工程
背景情况:
- 塔利莫基因拉赫帕雷普韦克 (T-VEC) 是第一个FDA批准的针对不可切除黑色素瘤的瘤病毒.
- T-VEC是从HSV-1中设计的,具有ICP34.5和ICP47基因删除和GM-CSF插入.
- 它的机制涉及瘤细胞溶解,抗原释放和通过树突细胞激活的全身免疫刺激.
研究的目的:
- 审查T-VEC的机制,临床结果和黑色素瘤和其他固体瘤的安全性.
- 探索T-VEC在非黑色素瘤癌症中的疗效以及与化疗/辐射的协同作用.
- 将T-VEC定位在病毒疗法领域,并应对输送和患者选择方面的挑战.
主要方法:
- 关于T-VEC的机制,临床试验和安全数据的文献综合.
- 探索乳腺癌和头角状细胞癌 (HNSCC) 最近的试验.
- 与其他型病毒 (HF-10,型病毒,麻疹变种) 的比较分析.
主要成果:
- T-VEC显示出超越黑色素瘤的潜力,包括乳腺癌和HNSCC.
- 新兴的应用突显了T-VEC在组合疗法中的多功能性.
- 挑战包括系统传递,免疫清除和生物标志物开发.
结论:
- 在癌症治疗中T-VEC的作用正在扩展到各种恶性瘤中.
- 优化T-VEC需要解决分娩,免疫逃避和患者选择.
- 新的组合和策略对于增强T-VEC的治疗潜力至关重要.
更多相关视频
08:55Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
Published on: April 15, 2016
9.4K
08:52Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
17.1K
相关概念视频
Tumor Immunotherapy
397
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
397
Cancer Vaccines
237
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
237
Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Rous Sarcoma Virus (RSV) and Cancer
4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
4.9K
